(English) After the American Society of Retinal Specialists (ASRS) shared a note with its membership warning of vision-threatening cases of occlusive retinal vasculitis of wet AMD drug Beovu, Novartis... Read More >
(English) Following the Euopean Medicines Agency (EMA) human medicine’s committee recommendation in December, Beovu (brolucizumab) received formal approval by the European Commission … Sour... Read More >
(English) In latest calculations, researchers pooled data from 22 prevalence studies involving 55,323 people, aged, on average, between 60 and 81, and from four incidence studies across Europe … ... Read More >
(English) At EURETINA 2019 Congress, the Australia based company Ophthea reported data that OPT-302 reduced areas of neovascularization by 38% more and decreased scarring by 39% more, compared to Luce... Read More >
(English) Analysis of data from a Phase 2 study of abicipar pegol (Anti-VEGF DARPin®) in neovascular, or “wet,” age-related macular degeneration (AMD) showed positive results, leading to the deci... Read More >
(English) The presence of vitreous separation may play a role in ranibizumab therapy for neovascular age-related macular degeneration, according to a poster presented at the Association for Research i... Read More >
Llamar a la acción
Aprenda cómo la detección precoz por un especialista en retina es vital para mantener su visión. Averigüe qué tratamientos están disponibles para usted. Acceda a los recursos adecuados. Juntos aumentaremos la concienciación.
